Cellular regeneration as a potential strategy to treat cardiac conduction disorders

Satadru K Lahiri1,2, Mohit M Hulsurkar1,2, Xander Ht Wehrens1,2,3,4,5,6

  • 1Cardiovascular Research Institute.

Insights

Cardiac conduction diseases stem from atrioventricular conduction system (AVCS) cell loss. Neonatal mice showed AVCS cell regeneration, suggesting a therapeutic window for cardiac repair.

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Molecular Biology

Background:

  • Loss of atrioventricular conduction system (AVCS) cells causes conduction diseases and fatal arrhythmias.
  • Current treatments for cardiac conduction diseases are limited.

Purpose of the Study:

  • To investigate the regenerative potential of AVCS cells.
  • To establish a mouse model for studying atrioventricular block (AVB).

Main Methods:

  • Induced AVCS cell-specific injury using Cx30.2 enhancer-driven diphtheria toxin fragment A expression in mice.
  • Compared AVCS cell ablation effects in adult and neonatal mice.

Main Results:

  • AVCS cell ablation in adult mice resulted in irreversible atrioventricular block (AVB).
  • Neonatal mice with AVCS cell injury exhibited spontaneous recovery, indicating a postnatal regenerative window.
  • Cellular plasticity in AVCS cells was observed during this limited postnatal period.

Conclusions:

  • A critical postnatal window exists for AVCS cell regeneration.
  • This finding opens avenues for biological and cellular therapies for cardiac conduction diseases.
  • Exploiting AVCS cell regenerative potential may offer new treatment strategies.